A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer
Clinical trial NCT05492045 · TERMINATED
Trial details
- NCT number
- NCT05492045
- Sponsor
- InventisBio Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2024-06-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.